Global Blood Screening Market 2023-2027
The blood screening market is forecasted to grow by USD 1,176.02 mn during 2022-2027, accelerating at a CAGR of 7.42% during the forecast period. The report on the blood screening market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing blood transfusion needs, mergers and acquisitions among vendors, and advancements in medical treatments.
Technavio's blood screening market is segmented as below:
By Component
- Reagents and kits
- Instruments
- Software and services
By End-user
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the automation in blood screening process as one of the prime reasons driving the blood screening market growth during the next few years. Also, increased awareness of bloodborne infections and diseases and increasing point-of-care testing will lead to sizable demand in the market.
The report on the blood screening market covers the following areas:
- Blood screening market sizing
- Blood screening market forecast
- Blood screening market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading blood screening market vendors that include Apollo Hospitals Enterprise Ltd., Aster Clinical Lab LLP, BCAL Diagnostics Ltd., Becton Dickinson and Co., Bio Rad Laboratories Inc., Dr Lal PathLabs Ltd., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Grifols SA, Harley Street Health Checks UK Ltd., Hemogenomics Pvt. Ltd., Laboratory Corp. of America Holdings, Mankind Pharma Ltd., Metropolis Healthcare Ltd., QuidelOrtho Corp., Siemens Healthineers AG, Syantra Inc., Thermo Fisher Scientific Inc., and Vijaya Diagnostic Centre Ltd.. Also, the blood screening market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.